Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor.

The mechanisms involved in the mobilization of progenitor cells into the blood by granulocyte colony-stimulating factor (G-CSF) and other cytokines are poorly understood. To identify important influences on this complex process, in vivo murine models were used. Granulocyte-macrophage colony-stimulating factor (GM-CSF) transgenic, Max41 transgenic, W/Wv, Mpl-null, GM-CSF receptor (beta chain)-null mice, wild-type littermate controls, and six inbred strains of mice were injected with 200 microg/kg/d G-CSF for 5 days. Three parameters of response were monitored: white blood cell count (WCC), peripheral blood progenitor cell (PBPC) numbers, and spleen weight. In all genotypes studied, G-CSF induced increases in these three parameters. However, PBPC mobilization in W/Wv and Mpl-null mice was only 30% and 9%, respectively, of that observed in wild-type mice. In contrast, perturbations of GM-CSF signalling had no demonstrable effect on in vivo responses to G-CSF. Broad variability was evident between inbred strains for each parameter of the response to G-CSF. A 10-fold range in response was observed for circulating progenitor cell numbers, similar to that observed for normal human subjects receiving G-CSF. The interstrain differences were in the distribution of mature and progenitor cells between peripheral blood, bone marrow, and spleen rather than in the total numbers of these cells in the body. Results of an F2 intercross of low-responding C57BL/6 and intermediate-responding SJL mice indicated that regulation of progenitor cell mobilization is a complex genetic trait, that there is a correlation between this trait and WCC response (r2 = .5), and that this approach may serve as a useful model for the identification of genes involved in the mobilization process.

[1]  W S Alexander,et al.  Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. , 1996, Blood.

[2]  A. Roberts,et al.  The regulation of hematopoiesis in max 41 transgenic mice with sustained excess granulopoiesis. , 1996, Leukemia.

[3]  A. Roberts,et al.  Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. , 1995, Blood.

[4]  C. Begley,et al.  Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Verfaillie,et al.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. , 1995, The Journal of clinical investigation.

[6]  G. Lindeman,et al.  Analysis of hematopoiesis in max 41 transgenic mice that exhibit sustained elevations of blood granulocytes and monocytes. , 1995, Blood.

[7]  M. Vadas,et al.  Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins , 1995, The Journal of experimental medicine.

[8]  T. Luft,et al.  Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. , 1994, Blood.

[9]  A. Roberts,et al.  Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. , 1994, Experimental hematology.

[10]  L. To,et al.  A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. , 1994, Blood.

[11]  A. W. Harris,et al.  B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain. , 1994, Immunity.

[12]  D. Metcalf Hematopoietic regulators: redundancy or subtlety? , 1993, Blood.

[13]  K. Smith,et al.  Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. , 1993, Blood.

[14]  A. Howell,et al.  Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants , 1993, The Lancet.

[15]  C. Begley,et al.  Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. , 1992, British Journal of Cancer.

[16]  I. Bernstein,et al.  A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons. , 1992, Blood.

[17]  K. Zsebo,et al.  The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. , 1991, Blood.

[18]  T. Dexter,et al.  Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. , 1991, Blood.

[19]  I. Weissman,et al.  Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis , 1991, The Journal of experimental medicine.

[20]  H. Nomura,et al.  Reduced response to granulocyte colony-stimulating factor in W/Wv and Sl/Sld mice. , 1991, Leukemia.

[21]  I. Hampson,et al.  Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. , 1990, Blood.

[22]  A. Ganser,et al.  Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. , 1990, Blood.

[23]  V. Diehl,et al.  Differential effects of recombinant human colony stimulating factor (rh G‐CSF) on stem cells in marrow, spleen and peripheral blood in mice , 1990, British journal of haematology.

[24]  M. Higuchi,et al.  Effects of recombinant human erythropoietin on anaemic W/Wv and SI/SId mice , 1990, British journal of haematology.

[25]  P. Valent,et al.  Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factor. , 1990, Blood.

[26]  T. Dexter,et al.  A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. , 1990, Blood.

[27]  J. Villeval,et al.  Effect of recombinant human granulocyte‐macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies , 1990, British journal of haematology.

[28]  A Howell,et al.  The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Villeval,et al.  Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. , 1988, Blood.

[30]  M. Baum,et al.  INFORMED CONSENT AND CONTROLLED TRIALS , 1988, The Lancet.

[31]  M. Socinski,et al.  GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN , 1988, The Lancet.

[32]  M. Green,et al.  EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY , 1988, The Lancet.

[33]  R. Cuthbertson,et al.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage , 1987, Cell.

[34]  C. Eaves,et al.  Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. , 1985, Blood.

[35]  N. Nicola,et al.  Binding of 125I‐labeled granulocyte colony‐stimulating factor to normal murine hemopoietic cells , 1985, Journal of cellular physiology.

[36]  T. Chard,et al.  Pregnancy-specific beta-glycoprotein in complications of early pregnancy. , 1980, Lancet.

[37]  G. Cartwright,et al.  Quantitative studies of blood and bone marrow neutrophils in normal mice. , 1968, The American journal of physiology.

[38]  J. P. Lewis,et al.  Growth and differentiation of transplanted W/Wv marrow. , 1967, Blood.

[39]  J. Till,et al.  Spleen-Colony Formation in Anemic Mice of Genotype WW , 1964, Science.